Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.

Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.

J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.

PMID:
29858347
2.

Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.

Stoll ML, Amin D, Powell KK, Poholek CH, Strait RH, Aban I, Beukelman T, Young DW, Cron RQ, Waite PD.

J Rheumatol. 2018 Aug;45(9):1301-1307. doi: 10.3899/jrheum.171306. Epub 2018 May 15.

PMID:
29764966
3.

Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

Stoll ML, Kau CH, Waite PD, Cron RQ.

Pediatr Rheumatol Online J. 2018 Apr 25;16(1):32. doi: 10.1186/s12969-018-0244-y. Review.

4.

Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.

Stoll ML, Pierce MK, Watkins JA, Zhang M, Weiss PF, Weiss JE, Elson CO, Cron RQ, Kumar R, Morrow CD, Schoeb TR.

Genes Immun. 2018 Mar 24. doi: 10.1038/s41435-018-0024-1. [Epub ahead of print]

PMID:
29599513
5.

Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.

Vinod SS, Reed AB, Maxwell J, Cron RQ, Stoll ML.

Pediatr Rheumatol Online J. 2018 Mar 9;16(1):16. doi: 10.1186/s12969-018-0234-0.

6.

Age and fecal microbial strain-specific differences in patients with spondyloarthritis.

Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, Danila MI, Spencer CH, Punaro MG, Schikler K, Reiff A, Kumar R, Cron RQ, Morrow CD, Lefkowitz EJ.

Arthritis Res Ther. 2018 Jan 30;20(1):14. doi: 10.1186/s13075-018-1510-6.

7.

Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis.

Stoll ML, Guleria S, Mannion ML, Young DW, Royal SA, Cron RQ, Vaid YN.

Pediatr Rheumatol Online J. 2018 Jan 24;16(1):8. doi: 10.1186/s12969-018-0223-3.

8.

Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.

Paul B, Royston KJ, Li Y, Stoll ML, Skibola CF, Wilson LS, Barnes S, Morrow CD, Tollefsbol TO.

PLoS One. 2017 Dec 21;12(12):e0189756. doi: 10.1371/journal.pone.0189756. eCollection 2017.

9.

Adiposity in Juvenile Psoriatic Arthritis.

Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D; CARRA Legacy Registry Investigators.

J Rheumatol. 2018 Mar;45(3):411-418. doi: 10.3899/jrheum.170598. Epub 2017 Dec 15.

PMID:
29247150
10.

Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.

Stoll ML, Grubbs JA, Beukelman T, Mannion ML, Jester TW, Cron RQ, Crain MJ.

Pediatr Rheumatol Online J. 2017 Nov 9;15(1):79. doi: 10.1186/s12969-017-0207-8.

11.

Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.

Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.

J Rheumatol. 2017 Nov;44(11):1632-1635. doi: 10.3899/jrheum.170263. Epub 2017 Sep 1.

PMID:
28864647
12.

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.

Spencer CH, Rouster-Stevens K, Gewanter H, Syverson G, Modica R, Schmidt K, Emery H, Wallace C, Grevich S, Nanda K, Zhao YD, Shenoi S, Tarvin S, Hong S, Lindsley C, Weiss JE, Passo M, Ede K, Brown A, Ardalan K, Bernal W, Stoll ML, Lang B, Carrasco R, Agaiar C, Feller L, Bukulmez H, Vehe R, Kim H, Schmeling H, Gerstbacher D, Hoeltzel M, Eberhard B, Sundel R, Kim S, Huber AM, Patwardhan A; Pediatric Rheumatologist Collaborators.

Pediatr Rheumatol Online J. 2017 Jun 13;15(1):50. doi: 10.1186/s12969-017-0174-0.

13.

The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.

Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED; CARRA Legacy Registry Investigators.

J Rheumatol. 2017 Mar;44(3):342-351. doi: 10.3899/jrheum.160717. Epub 2017 Feb 1.

PMID:
28148698
14.

Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.

Stoll ML, Kumar R, Lefkowitz EJ, Cron RQ, Morrow CD, Barnes S.

Genes Immun. 2016 Dec;17(7):400-405. doi: 10.1038/gene.2016.38. Epub 2016 Oct 27.

15.

Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis.

Mannion ML, McAllister L, Cron RQ, Stoll ML.

J Clin Rheumatol. 2016 Aug;22(5):282-4. doi: 10.1097/RHU.0000000000000408. No abstract available.

PMID:
27464779
16.

Gut microbiota-host interactions and juvenile idiopathic arthritis.

Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.

Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6. Review.

17.

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Stoll ML, Cron RQ.

Curr Opin Rheumatol. 2016 Sep;28(5):537-43. doi: 10.1097/BOR.0000000000000312. Review.

18.

Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.

Stoll ML, Vaid YN, Guleria S, Beukelman T, Waite PD, Cron RQ.

J Rheumatol. 2015 Nov;42(11):2155-9. doi: 10.3899/jrheum.150308. Epub 2015 Sep 1.

PMID:
26329345
19.

Gut microbes, immunity, and spondyloarthritis.

Stoll ML.

Clin Immunol. 2015 Aug;159(2):134-42. doi: 10.1016/j.clim.2015.05.001. Epub 2015 May 9. Review.

PMID:
25967460
20.

Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.

Tambralli A, Beukelman T, Cron RQ, Stoll ML.

J Rheumatol. 2015 Mar;42(3):541-6. doi: 10.3899/jrheum.140863. Epub 2015 Jan 15.

PMID:
25593242
21.

Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.

Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, Cron RQ, Elson CO.

Arthritis Res Ther. 2014 Nov 30;16(6):486. doi: 10.1186/s13075-014-0486-0.

22.

Treatment of juvenile idiopathic arthritis: a revolution in care.

Stoll ML, Cron RQ.

Pediatr Rheumatol Online J. 2014 Apr 23;12:13. doi: 10.1186/1546-0096-12-13. eCollection 2014. Review.

23.

Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.

Kimura Y, DeWitt EM, Beukelman T, Stoll ML, Nigrovic PA, Onel K, Prahalad S, Angeles-Han S, Schneider R; Juvenile Idiopathic Arthritis Disease-Specific Research Committee of the Childhood Arthritis and Rheumatology Research Alliance.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1430-1. doi: 10.1002/acr.22343. No abstract available.

24.

Treatment of juvenile idiopathic arthritis in the biologic age.

Stoll ML, Cron RQ.

Rheum Dis Clin North Am. 2013 Nov;39(4):751-66. doi: 10.1016/j.rdc.2013.05.004. Epub 2013 Jul 5. Review.

PMID:
24182853
25.

Imaging of the temporomandibular joint in juvenile idiopathic arthritis.

Vaid YN, Dunnavant FD, Royal SA, Beukelman T, Stoll ML, Cron RQ.

Arthritis Care Res (Hoboken). 2014 Jan;66(1):47-54. doi: 10.1002/acr.22177.

26.

High doses of infliximab in the management of juvenile idiopathic arthritis.

Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML.

J Rheumatol. 2013 Oct;40(10):1749-55. doi: 10.3899/jrheum.130133. Epub 2013 Aug 15.

PMID:
23950184
27.

Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies.

Henderson LA, Loring SH, Gill RR, Liao KP, Ishizawar R, Kim S, Perlmutter-Goldenson R, Rothman D, Son MB, Stoll ML, Zemel LS, Sandborg C, Dellaripa PF, Nigrovic PA.

J Rheumatol. 2013 Mar;40(3):273-81. doi: 10.3899/jrheum.121048. Epub 2013 Feb 1.

28.

Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.

Stoll ML, Morlandt AB, Teerawattanapong S, Young D, Waite PD, Cron RQ.

Rheumatology (Oxford). 2013 Mar;52(3):554-9. doi: 10.1093/rheumatology/kes318. Epub 2012 Dec 5.

PMID:
23221325
29.

Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF(1) mice.

Nyland JF, Stoll ML, Jiang F, Feng F, Gavalchin J.

Lupus. 2012 Dec;21(14):1552-64. doi: 10.1177/0961203312461964. Epub 2012 Sep 26.

PMID:
23015610
30.

Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.

Stoll ML, Sharpe T, Beukelman T, Good J, Young D, Cron RQ.

J Rheumatol. 2012 Sep;39(9):1880-7. doi: 10.3899/jrheum.111441. Epub 2012 May 15.

PMID:
22589268
31.

MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis.

Stoll ML, Patel AS, Punaro M, Dempsey-Robertson M.

Pediatr Rheumatol Online J. 2012 Feb 8;10:6. doi: 10.1186/1546-0096-10-6.

32.

Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.

DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, Schikler KN, Vehe RK, Weiss JE, Weiss P, Ilowite NT, Wallace CA; Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1001-10. doi: 10.1002/acr.21625.

33.

Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.

Stoll ML, Good J, Sharpe T, Beukelman T, Young D, Waite PD, Cron RQ.

J Oral Maxillofac Surg. 2012 Aug;70(8):1802-7. doi: 10.1016/j.joms.2011.11.003. Epub 2012 Jan 21.

PMID:
22265164
34.

IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis.

Stoll ML, Patel AS, Christadoss ML, Punaro M, Olsen NJ.

Ann Paediatr Rheumatol. 2012;1(1):31-35.

35.

17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis.

Feng F, Silvin CJ, Fiore NC, Stoll ML, Price KE, Shanley PS, Silverstone AE, Gavalchin J.

Lupus. 2012 Mar;21(3):288-301. doi: 10.1177/0961203311425519. Epub 2011 Nov 7.

PMID:
22065096
36.

Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.

Stoll ML, Punaro M, Patel AS.

J Rheumatol. 2011 Oct;38(10):2274-5. doi: 10.3899/jrheum.110508. No abstract available.

37.

Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.

Stoll ML, Li QZ, Zhou J, Punaro M, Olsen NJ.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):736-42. Epub 2011 Sep 1.

38.

Psoriatic juvenile idiopathic arthritis: a tale of two subgroups.

Stoll ML, Punaro M.

Curr Opin Rheumatol. 2011 Sep;23(5):437-43. doi: 10.1097/BOR.0b013e328348b278. Review.

PMID:
21709556
39.

Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis.

Stoll ML, Nigrovic PA, Gotte AC, Punaro M.

Clin Exp Rheumatol. 2011 May-Jun;29(3):582-8. Epub 2011 Jun 30.

40.

Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Stoll ML.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):322-30. Epub 2011 Apr 19. Review.

41.

Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.

Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M.

J Rheumatol. 2010 Nov;37(11):2402-8. doi: 10.3899/jrheum.100014. Epub 2010 Aug 3.

42.

Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severity.

Simard JF, Stoll ML, Shadick NA, Karlson EW, Solomon DH.

J Clin Epidemiol. 2010 Dec;63(12):1358-62. doi: 10.1016/j.jclinepi.2010.01.014. Epub 2010 Apr 28.

43.

TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.

Stoll ML, Solomon DH, Batra KL, Simard JF, Karlson EW, Dellaripa PF, Weinblatt ME, Glass R, Shadick NA.

J Clin Rheumatol. 2009 Jun;15(4):198-200. doi: 10.1097/RHU.0b013e3181a7ace9. No abstract available.

44.

Conservation and diversity of Foxp2 expression in muroid rodents: functional implications.

Campbell P, Reep RL, Stoll ML, Ophir AG, Phelps SM.

J Comp Neurol. 2009 Jan 1;512(1):84-100. doi: 10.1002/cne.21881.

46.

Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis.

Stoll ML, Lio P, Sundel RP, Nigrovic PA.

Arthritis Rheum. 2008 Jan 15;59(1):51-8. doi: 10.1002/art.23240.

47.
48.

Subpopulations within juvenile psoriatic arthritis: a review of the literature.

Stoll ML, Nigrovic PA.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):377-80. Review.

49.

Patients with juvenile psoriatic arthritis comprise two distinct populations.

Stoll ML, Zurakowski D, Nigrovic LE, Nichols DP, Sundel RP, Nigrovic PA.

Arthritis Rheum. 2006 Nov;54(11):3564-72.

Supplemental Content

Loading ...
Support Center